Holen Sie sich die Stockscreener-App
206.63
1.12%
2.29
Handel nachbörslich:
203.93
-2.70
-1.31%
Schlusskurs vom Vortag:
$204.34
Offen:
$204.95
24-Stunden-Volumen:
1.73M
Relative Volume:
1.12
Marktkapitalisierung:
$35.13B
Einnahmen:
$15.70B
Nettoeinkommen (Verlust:
$1.24B
KGV:
29.93
EPS:
6.9036
Netto-Cashflow:
$2.01B
1W Leistung:
+15.08%
1M Leistung:
+11.92%
6M Leistung:
+23.22%
1J Leistung:
-9.13%
1-Tages-Spanne:
$204.11
$209.48
1-Wochen-Bereich:
$177.08
$209.48
52-Wochen-Spanne:
$134.65
$237.34
Iqvia Holdings Inc Stock (IQV) Company Profile
Firmenname
Iqvia Holdings Inc
Sektor
Branche
Telefon
919-998-2000
Adresse
2400 ELLIS ROAD, DURHAM, NC
Vergleichen Sie IQV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
206.63 | 34.74B | 15.70B | 1.24B | 2.01B | 6.9036 |
|
TMO
Thermo Fisher Scientific Inc
|
543.32 | 198.23B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
214.99 | 150.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
631.19 | 50.71B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.64 | 39.32B | 6.79B | 1.22B | 1.09B | 4.2644 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-09 | Hochstufung | Jefferies | Hold → Buy |
| 2025-04-25 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-02-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-12-20 | Eingeleitet | Stephens | Overweight |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-09-04 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-06-06 | Eingeleitet | Goldman | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-15 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-02-13 | Eingeleitet | BTIG Research | Buy |
| 2023-11-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-03-17 | Eingeleitet | Truist | Buy |
| 2022-12-06 | Eingeleitet | Cowen | Outperform |
| 2022-11-17 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-15 | Eingeleitet | SVB Leerink | Outperform |
| 2022-05-24 | Eingeleitet | Guggenheim | Buy |
| 2022-04-29 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-16 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2020-07-07 | Eingeleitet | Stephens | Equal-Weight |
| 2020-03-02 | Eingeleitet | Deutsche Bank | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-12-13 | Hochstufung | CFRA | Sell → Hold |
| 2019-11-14 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | Hochstufung | Mizuho | Neutral → Buy |
| 2019-05-28 | Eingeleitet | SVB Leerink | Outperform |
| 2019-01-18 | Hochstufung | Jefferies | Hold → Buy |
| 2018-10-09 | Eingeleitet | UBS | Buy |
| 2018-10-02 | Bestätigt | Robert W. Baird | Outperform |
| 2018-07-25 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | Bestätigt | Stifel | Buy |
| 2018-07-03 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | Hochstufung | Goldman | Neutral → Buy |
| 2018-03-07 | Hochstufung | SunTrust | Hold → Buy |
| 2018-01-19 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Iqvia Holdings Inc Aktie (IQV) Neueste Nachrichten
Is IQVIA Holdings Inc. stock a safe haven assetJuly 2025 Fed Impact & Free Long-Term Investment Growth Plans - newser.com
How to use a screener to detect IQVIA Holdings Inc. breakoutsWeekly Profit Report & Expert Curated Trade Setup Alerts - newser.com
What high frequency data says about IQVIA Holdings Inc.2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - newser.com
Is it too late to sell IQVIA Holdings Inc.2025 Volatility Report & Intraday High Probability Alerts - newser.com
Will IQVIA Holdings Inc. stock recover faster than peersBond Market & Daily Growth Stock Tips - newser.com
Will IQVIA Holdings Inc. stock benefit from infrastructure billPortfolio Growth Summary & Technical Buy Zone Confirmation - newser.com
Press Release: IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025 - 富途牛牛
IQVIA Holdings Hits Day High with 7.5% Surge in Strong Intraday Performance - Markets Mojo
Could IQVIA’s (IQV) Expanded Vaccine Analytics Signal a New Phase in Its Healthcare Partnerships? - Yahoo Finance
IQVIA Holdings Inc. (IQV) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
What hedge fund moves indicate for IQVIA Holdings Inc. stockSell Signal & Community Consensus Trade Alerts - newser.com
Developing predictive dashboards with IQVIA Holdings Inc. dataWeekly Gains Summary & Step-by-Step Swing Trade Plans - newser.com
Relative strength of IQVIA Holdings Inc. in sector analysisPortfolio Return Summary & Safe Entry Momentum Tips - newser.com
Analyzing IQVIA Holdings Inc. with multi timeframe chartsTrade Performance Summary & AI Forecast for Swing Trade Picks - newser.com
Will IQVIA Holdings Inc. stock beat international competitionWeekly Trade Review & Risk Managed Investment Entry Signals - newser.com
What recovery options are there for IQVIA Holdings Inc.2025 Dividend Review & Real-Time Market Trend Scan - newser.com
Barclays Maintains Rating and Raises Price Target for IQVIA (IQV - GuruFocus
Barclays Adjusts Price Target on IQVIA Holdings Inc to $200 From $185, Maintains Equalweight Rating - MarketScreener
Why IQVIA (IQV) Stock Is Trading Up Today - Yahoo Finance
Real World Evidence Solutions Research and Forecast Report 2025-2030: Growth Opportunities in Emerging Markets and Increased Focus on End-To-End Rwe Services, & Personalized and Precision Medicine - GlobeNewswire Inc.
IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025 - BioSpace
What Makes IQVIA (IQV) an Attractive Investment? - MSN
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know - Barchart.com
IQVIA Spikes: Is It a Rising Star? - StocksToTrade
Decoding the Sudden Surge in IQVIA Stock: A Close Look - timothysykes.com
Is IQVIA Holdings Inc a good long term investmentProtective Put Strategies & Free Fastest Return On Investment - earlytimes.in
Raleigh Capital Management Inc. Raises Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
Is IQVIA Holdings Inc. stock in correction or buying zoneGap Up & Stepwise Entry and Exit Trade Signals - newser.com
What drives IQVIA Holdings Inc stock priceMomentum Stock Picks & Free Rapid Wealth Building - earlytimes.in
How IQVIA Holdings Inc. stock trades in high volatilityJuly 2025 Institutional & Long-Term Investment Growth Plans - newser.com
Patton Fund Management Inc. Acquires New Shares in IQVIA Holdings Inc. $IQV - MarketBeat
What Are Wall Street Analysts' Target Price for IQVIA Holdings Stock? - MSN
Finanzdaten der Iqvia Holdings Inc-Aktie (IQV)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.12%
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):